EPISODE · Jan 20, 2021 · 7 MIN
Silo Pharma Inc. Discusses The Potential of Merging Traditional Therapeutics with Psychedelic Research On The Stock Day Podcast
from Stock Day Media · host Stock Day Media
The Stock Day Podcast welcomed Silo Pharma Inc. (SILO)(“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders. CEO of the Company, Eric Weisblum, joined Stock Day host Everett Jolly. READ FULL ARTICLE: https://stockdaymedia.com/silo-pharma-inc-discusses-the-potential-of-merging-traditional-therapeutics-with-psychedelic-research-on-the-stock-day-podcast-silo-january-20-2021/ Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
The Stock Day Podcast welcomed Silo Pharma Inc. (SILO)(“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders. CEO of the Company, Eric Weisblum, joined Stock Day host Everett Jolly. READ FULL ARTICLE: https://stockdaymedia.com/silo-pharma-inc-discusses-the-potential-of-merging-traditional-therapeutics-with-psychedelic-research-on-the-stock-day-podcast-silo-january-20-2021/ Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
Silo Pharma Inc. Discusses The Potential of Merging Traditional Therapeutics with Psychedelic Research On The Stock Day Podcast
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.